- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Deutsch
- Bibliographic citation
-
Aktivierung natürlicher Killerzellen zur Behandlung von Tumorerkrankungen ; volume:29 ; number:6 ; day:19 ; month:10 ; year:2023 ; pages:603-605 ; date:10.2023
Biospektrum ; 29, Heft 6 (19.10.2023), 603-605, 10.2023
- Keyword
-
Natürliche Killerzelle
Krebs
Immuntherapie
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12268-023-2022-8
- URN
-
urn:nbn:de:101:1-2024010810093671734384
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Harwardt, Julia
- Schoenfeld, Katrin
- Kolmar, Harald
- SpringerLink (Online service)
Other Objects (12)
T-Zell-vermittelte Aktivierung natürlicher Killerzellen
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Hybrid Multimeric Architectures for Enhanced Receptor Targeting and Intracellular Delivery of Bioactive Cargoes
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Modulation of autophagy impacts the fate of senescent skin fibroblasts
Ultra-High-Throughput Single-Cell Functional Screening by Combination of Microfluidics and GMD-FACS
Chemical synthesis of membrane-associated peptides: A model study on influenza virus B protein BM2(1-51)
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Merge Two into One: Multispecific Symmetric Antibodies for Cancer Immunotherapy
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis
Flavors of biotin ligases: From research tools towards biopharmaceutical applications
T-Zell-vermittelte Aktivierung natürlicher Killerzellen
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Hybrid Multimeric Architectures for Enhanced Receptor Targeting and Intracellular Delivery of Bioactive Cargoes
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Modulation of autophagy impacts the fate of senescent skin fibroblasts
Ultra-High-Throughput Single-Cell Functional Screening by Combination of Microfluidics and GMD-FACS
Chemical synthesis of membrane-associated peptides: A model study on influenza virus B protein BM2(1-51)
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Merge Two into One: Multispecific Symmetric Antibodies for Cancer Immunotherapy
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis
Flavors of biotin ligases: From research tools towards biopharmaceutical applications
T-Zell-vermittelte Aktivierung natürlicher Killerzellen
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Hybrid Multimeric Architectures for Enhanced Receptor Targeting and Intracellular Delivery of Bioactive Cargoes
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Modulation of autophagy impacts the fate of senescent skin fibroblasts
Ultra-High-Throughput Single-Cell Functional Screening by Combination of Microfluidics and GMD-FACS
Chemical synthesis of membrane-associated peptides: A model study on influenza virus B protein BM2(1-51)
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Merge Two into One: Multispecific Symmetric Antibodies for Cancer Immunotherapy
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis